Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.4800
-0.0030 (-0.62%)
Apr 28, 2025, 10:00 AM EDT - Market open

Calidi Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
172254100282-
Market Cap Growth
-58.52%-58.52%-46.70%-64.38%--
Enterprise Value
153053105--
Last Close Price
0.481.1515.10101.7098.10-
PS Ratio
---2232.43628.15-
PB Ratio
7.1011.29-6.50-2.46-12.47-
P/TBV Ratio
11.4414.48----
EV/Sales Ratio
---2340.39--
Debt / Equity Ratio
3.583.58-0.88-0.15-0.23-0.87
Asset Turnover
---0.020.17-
Quick Ratio
1.011.010.190.010.080.05
Current Ratio
1.081.080.420.020.110.06
Return on Assets (ROA)
-112.47%-112.47%-287.25%-482.80%-229.02%-
Return on Capital (ROIC)
-340.04%-340.04%----
Earnings Yield
-135.75%-99.68%-54.56%-25.31%-3.88%-
FCF Yield
-112.35%-88.73%-51.48%-13.58%-2.83%-
Buyback Yield / Dilution
-374.79%-374.79%-98.24%56.93%-15.26%-
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q